FDA alerted on abort drug

Share this article:
The FDA says it is investigating two more US deaths associated with the medical abortion drug Mifeprex (mifepristone) that were recently reported to the agency by the manufacturer, Danco Laboratories. The FDA has only received verbal notification about the deaths, it says, adding that “we are investigating all circumstances associated with these cases and are not able to confirm the causes of death.”

Last year, an FDA alert confirmed four previous deaths from sepsis that occurred between 2003 and 2005. All four cases tested positive for Clostridium sordellii and involved an off-label dosing regimen.
Concerned Women for America is calling on the FDA to pull Mifeprex from the market, saying it “has pulled other drugs that have caused fewer deaths and less severe complications. ... Why the double standard for an abortion drug that is now linked to the deaths of seven healthy women and over 800 other reported complications?”

The conservative advocacy group said the FDA pulled the imaging agent NeutroSpec after it was linked to two deaths, 20 severe reactions and 46 other less severe reactions. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

Steve Cashman, Founder and CEO, HealthSpot

Recruitment: The New Breed

Recruitment: The New Breed

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and ...

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the September 2014 issue of MM&M, with all text, charts and pictures.